The enrichment of significant overexpression on IL18RAP, IL18R1, IL1R1, IL2RB, and IL4R indicated that CNL resembled an inflammatory signature of secondary AML (Supplementary Figure 9). The gene discussed is IL18RAP; the disease is acute myeloid leukemia.